TY - JOUR
T1 - The relationship between repeated measurement of casual and 24-h urinary sodium-to-potassium ratio in patients with chronic kidney disease
AU - Okuyama, Yuka
AU - Uchida, Haruhito A.
AU - Iwahori, Toshiyuki
AU - Segawa, Hiroyoshi
AU - Kato, Ayako
AU - Takeuchi, Hidemi
AU - Kakio, Yuki
AU - Umebayashi, Ryoko
AU - Kitagawa, Masashi
AU - Sugiyama, Hitoshi
AU - Miura, Katsuyuki
AU - Ueshima, Hirotsugu
AU - Wada, Jun
N1 - Funding Information:
Funding This work was supported by a scientific research grants from Japanese Study Group for Physiology and Management of Blood Pressure.
Funding Information:
Conflict of interest Dr. Haruhito A. Uchida belongs to the Department of Chronic Kidney Disease and Cardiovascular Disease which is endowed by Chugai pharmaceutical, MSD, Boehringer Ingelheim, and Kawanishi Holdings. Dr. Toshiyuki Iwahori was an employee of OMRON HEALTHCARE Co., Ltd. until March, 2018. Dr. Hirotsugu Ueshima served as a consultant for this project. Dr. Katsuyuki Miura received a research grant from OMRON HEALTHCARE Co., Ltd.
Publisher Copyright:
© 2018, Springer Nature Limited.
PY - 2019/4/1
Y1 - 2019/4/1
N2 - This study aimed to clarify the relationship between repeated measurements of casual (spot) and 24-h urinary sodium-to-potassium (Na/K) ratios in patients with chronic kidney disease (CKD). A total of 61 inpatients with CKD, 31 in stage 1–3 (eGFR [estimated glomerular filtration rate] ≥ 30 ml/min/1.73 m 2 ) and 30 in stage 4–5 (eGFR < 30 ml/min/1.73 m 2 ), aged 20–85 consuming a low-sodium diet (NaCl [sodium chloride] 6 g/day) were recruited. Urinary Na, K, and Na/K ratios were measured in both casual urine samples and 2-day, 24 h urine samples, and then analyzed by correlation and Bland–Altman analyses. Mean 24-h urine Na/K ratio was higher in participants in stage 4–5 (5.1) than in participants in stage 1–3 (4.1) CKD. Casual urine Na/K ratio was strongly correlated with 2-day, 24-h urine Na/K ratio by sampling 4 casual urine specimens every morning and evening in participants in stage 1–3 (r = 0.69–0.78), but not in stage 4–5 (r = 0.12–0.19). The bias for mean Na/K ratio between 2-day, 24-h urine, and the 4 casual urine sampling ranged from −0.86 to 0.16 in participants in stage 1–3, and the quality of agreement for the mean of this casual urine sampling was similar to that of sampling 8 casual urine samples for estimating 2-day, 24-h values. Methods using repeated casual urine Na/K ratios may provide a reasonable estimation of 24-h urine Na/K ratio in normotensive and hypertensive as well as individuals with stage 1–3, but not stage 4–5 CKD.
AB - This study aimed to clarify the relationship between repeated measurements of casual (spot) and 24-h urinary sodium-to-potassium (Na/K) ratios in patients with chronic kidney disease (CKD). A total of 61 inpatients with CKD, 31 in stage 1–3 (eGFR [estimated glomerular filtration rate] ≥ 30 ml/min/1.73 m 2 ) and 30 in stage 4–5 (eGFR < 30 ml/min/1.73 m 2 ), aged 20–85 consuming a low-sodium diet (NaCl [sodium chloride] 6 g/day) were recruited. Urinary Na, K, and Na/K ratios were measured in both casual urine samples and 2-day, 24 h urine samples, and then analyzed by correlation and Bland–Altman analyses. Mean 24-h urine Na/K ratio was higher in participants in stage 4–5 (5.1) than in participants in stage 1–3 (4.1) CKD. Casual urine Na/K ratio was strongly correlated with 2-day, 24-h urine Na/K ratio by sampling 4 casual urine specimens every morning and evening in participants in stage 1–3 (r = 0.69–0.78), but not in stage 4–5 (r = 0.12–0.19). The bias for mean Na/K ratio between 2-day, 24-h urine, and the 4 casual urine sampling ranged from −0.86 to 0.16 in participants in stage 1–3, and the quality of agreement for the mean of this casual urine sampling was similar to that of sampling 8 casual urine samples for estimating 2-day, 24-h values. Methods using repeated casual urine Na/K ratios may provide a reasonable estimation of 24-h urine Na/K ratio in normotensive and hypertensive as well as individuals with stage 1–3, but not stage 4–5 CKD.
UR - http://www.scopus.com/inward/record.url?scp=85056722015&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056722015&partnerID=8YFLogxK
U2 - 10.1038/s41371-018-0127-1
DO - 10.1038/s41371-018-0127-1
M3 - Article
C2 - 30443006
AN - SCOPUS:85056722015
SN - 0950-9240
VL - 33
SP - 286
EP - 297
JO - Journal of Human Hypertension
JF - Journal of Human Hypertension
IS - 4
ER -